CD8A and cancer: Nevertheless, in the context of tumors, HOPX might facilitate the rapid enrichment of CD8+ T cells, neoantigen-reactive CD4+ T cells, and possibly their corresponding receptors within the TME, which in turn boosts the immune system to combat cancer.